Dione Shelton

Dione Shelton supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurements that enable public health surveillance, laboratory diagnostics, and scientific research. Responsible for managing complex acquisition strategies, Shelton facilitates the procurement of advanced analytical instruments, technical consulting services, and data-driven public health solutions critical to disease detection and response. Her work directly supports CDC’s operational readiness by ensuring timely access to high-performance laboratory systems and expert scientific support, aligning procurement decisions with national health security priorities. Shelton maintains established relationships with leading providers in biomedical and public health technology, including General Dynamics Information Technology, GlaxoSmithKline, Cepheid, MRIGLOBAL, and the New York City Health & Hospitals Corp. These partnerships reflect a focus on high-capacity, mission-aligned vendors capable of delivering specialized diagnostic platforms, clinical research support, and large-scale public health infrastructure services. Her contracting approach emphasizes reliability, technical rigor, and scalability, often engaging contractors with proven track records in federal health programs and regulated environments. Shelton’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on accessing the broadest possible pool of technical expertise and industrial capacity to meet urgent public health demands, rather than prioritizing socioeconomic set-asides. While small business participation is not formally targeted, all procurements adhere to federal competition requirements and value performance, innovation, and mission fit above socioeconomic categorization. Her primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing), 541690 (scientific and technical consulting), and 541990 (other professional services), underscoring expertise in procuring next-generation diagnostic equipment, epidemiological data systems, and life sciences R&D support. Shelton’s work centers on acquiring cutting-edge tools for pathogen detection, biosafety-compliant lab infrastructure, and analytical software critical to CDC’s real-time public health response capabilities.